SARMs are a possibly safer alternative to Androgenic Anabolic Steroids (AAS). In general, SARMs have fewer side effects than steroids and do not cause the same amount of suppression. Therefore, people wonder if they need a PCT (Post Cycle Therapy) after using SARMs.
In this article, we intend to get to the bottom of this question. We will discuss if and why a PCT is important after a SARM cycle.
What is a PCT?
When you use testosterone or any other androgenic anabolic steroid, your body gets a signal that there is enough testosterone available. As a result, the natural production of testosterone will decrease. When you finish your cycle, hormone levels will be low. In order to prevent losing your hard-earned muscle mass, a PCT (Post Cycle Therapy) is pretty much a must.
Do SARMs need PCT?
The short answer to this question is yes; we believe a PCT after a SARM cycle is important.
Although SARMs do not cause the same amount of suppression that androgenic steroids do, they will still have an impact on natural testosterone levels. Symptoms of low hormone levels include reduced libido, fatigue, insomnia, decreased muscle mass, and emotional changes.
You’re going to need a PCT to recover as fast as possible.
Will ostarine require a PCT?
Ostarine (MK-2866) is by far one of the most popular SARMs around. It is also the mildest one, giving the least amount of suppression. Any dip in natural testosterone levels will quickly return back to baseline after the use is discontinued. As such, we believe that Ostarine does not require a PCT when it has not been used in extremely high dosages during a prolonged period of time.
Will LGD 4033 require a PCT?
Ligandrol (LGD-4033) is one of the most potent SARMs currently available. It has a powerful effect on increasing muscle mass and strength and will cause a serious amount of suppression.
If you plan to use LGD 4033 for a long amount of time or at a high dosage, the use of Nolvadex is advised.
Which SARMs do not require a PCT?
There are a number of compounds that do not require a PCT, but these substances actually aren’t SARMs because they don’t target the androgen receptors. This includes SR9009, GW501516, and MK677.